JPMORGAN CHASE & CO

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in INO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$9,543

+$9,470 QoQ

Shares Held

5,485

+12959.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. INO ranks #298 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,543	5,485	+12959.5%	Shares	Defined	2026-05-13
2025-12-31	$73	42	-99.9%	Shares	Defined	2026-02-11
2025-09-30	$152,580	65,206	+1667.1%	Shares	Defined	2025-11-26
2025-06-30	$7,526	3,690	-79.1%	Shares	Defined	2025-08-12
2025-03-31	$28,737	17,631	+47.6%	Shares	Defined	2025-05-12
2024-12-31	$21,856	11,944	+1.6%	Shares	Defined	2025-02-12
2024-09-30	$67,936	11,754	+4.1%	Shares	Defined	2024-12-26
2024-06-30	$91,270	11,296	+2288.2%	Shares	Defined	2024-12-26
2024-03-31	$6,565	473	—	Shares	Defined	2024-12-26
No filing history on record for this holder in this stock.